Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glycoengineered Recombinant Alpha1-Antitrypsin Results in Comparable In Vitro and In Vivo Activities to Human Plasma-Derived Protein.

Biotechnology and bioengineering·2026
Same author

Z variant heterozygosity in alpha-1 antitrypsin deficiency: disease risk and treatment implications.

Orphanet journal of rare diseases·2026
Same author

Amplification of genetic and metabolic factors in alpha-1 antitrypsin deficiency.

Hepatology (Baltimore, Md.)·2026
Same author

Circular RNAs are differentially expressed in cystic fibrosis bronchial epithelium and regulate ion conductance.

American journal of respiratory cell and molecular biology·2026
Same author

MicroRNA-enriched EVs from mesenchymal stromal cells: a novel approach to suppress biofilm and inflammation in CF airway epithelium.

American journal of physiology. Lung cellular and molecular physiology·2026
Same author

Editors' Choice 2025 <italic>Journal of Innate Immunity</italic>: From Receptor Proximal Training to Metabolic and Fibrotic Control.

Journal of innate immunity·2026
Same journal

Eight-week high-intensity inspiratory muscle training improves cardiac autonomic function in COPD: a randomised controlled trial.

Respiratory medicine·2026
Same journal

Respiratory Muscle Strength, Functional Exercise Capacity, and Muscle Oxygenation Differences Between COPD, PRISM, and Healthy Controls.

Respiratory medicine·2026
Same journal

Prediction of therapeutic effect of antifibrotic therapy for idiopathic pulmonary fibrosis using quantitative CT texture analysis.

Respiratory medicine·2026
Same journal

Obesity and Early Sepsis-Associated Acute Respiratory Distress Syndrome: A Prospective Multicenter Study.

Respiratory medicine·2026
Same journal

Adults with congenital lung malformations: A descriptive analysis of an underexplored population.

Respiratory medicine·2026
Same journal

Risk factors and microbiological characteristics of ventilator-associated pneumonia in a Tunisian intensive care unit during the COVID-19 pandemic.

Respiratory medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 14, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

Alpha-1 antitrypsin deficiency.

Emer Kelly1, Catherine M Greene, Tomas P Carroll

  • 1Department of Respiratory Research, Royal College of Surgeons in Ireland, Beaumont Hospital, Education Research Building, Beaumont Road, Dublin, Ireland. emerkelly@rcsi.ie

Respiratory Medicine
|March 23, 2010
PubMed
Summary
This summary is machine-generated.

Alpha-1 antitrypsin (AAT) deficiency is a genetic disorder affecting the lungs and liver. This review summarizes current knowledge on AAT deficiency, including its clinical aspects, genetics, and treatment.

More Related Videos

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

Related Experiment Videos

Last Updated: Jun 14, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

Area of Science:

  • Genetics and Medicine

Background:

  • Alpha-1 antitrypsin (AAT) deficiency is an inherited condition with significant pulmonary and hepatic manifestations.
  • It is an autosomal co-dominant disorder with variable clinical penetrance.

Purpose of the Study:

  • To provide a comprehensive review of alpha-1 antitrypsin (AAT) deficiency.
  • To summarize key aspects including clinical features, epidemiology, genetics, pathophysiology, and management.

Main Methods:

  • A narrative literature review was conducted.
  • Existing research and clinical data on AAT deficiency were synthesized.

Main Results:

  • Extensive research has advanced understanding of AAT deficiency.
  • While many questions have been addressed, further research is needed to fully elucidate the condition.

Conclusions:

  • AAT deficiency predominantly impacts the lungs and liver.
  • The review covers clinical manifestations, prevalence, genetics, molecular pathophysiology, screening, and treatment recommendations for AAT deficiency.